Überprüfung…
Automatisch übersetzt. Dosierung und Warnhinweise: bitte im englischen Original prüfen. Auf Englisch lesen
Homepage / Eingetragen in Nigeria / 5% Dextrose (500/1000 mL)

5% Dextrose (500/1000 mL)

NAFDAC Reg.-Nr. 04-0857 Medikament

Registriert bei NAFDAC. Registrierung aktivAs of 4 November 2026 · synced automatically from official sources.
Produkt-
5% Dextrose (500/1000 mL)
NAFDAC-Nummer
04-0857
Wirkstoff
Anhydrous Dextrose
Stärke
5%
Form
Solution for infusion
VPE:
500 mL; 1000 mL (in Viaflo pouches)
Hersteller
Nicht aufgeführt
Applicant (holder)
Dana Pharmaceuticals Limited
Approved
3 Aug 2021
Status
Inactive View on NAFDAC ↗
Registration valid to
2 Aug 2026
WER WARNT
None found
Community reports
None
Times checked
0

About the medicine: Anhydrous dextrose: uses, dosage and brands worldwide

What we found

  • 5% Dextrose (500/1000 mL) is on the NAFDAC register with an active registration (04-0857). A valid number alone does not prove a pack is genuine — counterfeiters copy real numbers, so also check the expiry date, seal and print quality.

Generated automatically from the NAFDAC register, WHO alerts and community data as of today. This is not medical advice. Always follow your doctor or pharmacist.

How to use 5% Dextrose (500/1000 mL)

What the official label says. If a doctor prescribed it, follow the prescription. Your pack's leaflet comes first if it is different.

Who it is for

Elliotts B Solution is indicated as a diluent for the intrathecal administration of methotrexate sodium and cytarabine for the prevention or treatment of meningeal leukemia or lymphocytic lymphoma.

How to take it and how often
  • See product labeling for methotrexate sodium and cytarabine
  • Elliotts B Solution is intended for intrathecal administration only
  • Elliotts B Solution does not contain antibacterial preservatives and introduction of contaminated solutions into the cerebrospinal fluid may have extremely serious consequences
  • Therefore, administration of intrathecal solutions should be accomplished as soon as possible after preparation
  • A sterile filter-needle should be used to withdraw the contents of the ampule
  • Intrathecal drug products should be inspected visually for particulate matter and discoloration prior to administration
  • Preparation and Administration Precautions Elliotts B Solution is a diluent for the cytotoxic anticancer agents, methotrexate sodium and cytarabine
  • Care should be exercised in the handling and preparation of infusion solutions with these products. (See product labeling for methotrexate sodium and cytarabine.)
Talk to a doctor first if

None known.

Warnings

Intrathecal administration of drugs such as methotrexate sodium and cytarabine should be performed by personnel skilled in the technique of lumbar puncture under the supervision of a physician who is experienced in the use of cancer chemotherapeutic agents. The labeling for methotrexate sodium and cytarabine should be consulted.

Possible side effects

Adverse reactions may occur with any given intrathecal injection due to the chemotherapy or the technique of intrathecal administration. (See product labeling for methotrexate sodium and cytarabine.) Preservative-free methotrexate sodium and cytarabine should be used to minimize adverse reactions due to preservatives. If an adverse reaction does occur, discontinue the administration, evaluate the patient, institute appropriate therapeutic countermeasures and, if possible, save the remainder of the unused solution(s) for examination.

Pregnancy and breastfeeding

Usage in Pregnancy All components of Elliotts B Solution are normal body constituents. Animal reproduction studies have not been conducted with Elliotts B Solution.

If you take too much

Elliotts B Solution is a diluent. In the event of a drug, fluid or solute overload following administration, evaluate the patient's condition, and institute appropriate corrective treatment. (See product labeling for methotrexate sodium and cytarabine.)

Dependence and misuse

There is no potential for drug abuse or drug dependence.

If you miss a dose

Take it when you remember, unless it is nearly time for the next dose. Then skip the missed one. Never take two doses at once to make up for it. Check your leaflet, as some medicines are different.

From the official U.S. FDA label for this active ingredient. Your pack may have a different strength, so always read its leaflet. If a doctor prescribed it, follow the prescription. Ask a pharmacist if you are unsure. Label dated 2024-10-16.

Label for anhydrous dextrose, the active ingredient registered with NAFDAC.

Check your pack of 5% Dextrose (500/1000 mL)

Add the expiry date on your pack for a full Trust Score.

Or take photos of the pack
3 free checks left today Official sources: U.S. FDA · EMA (EU) · Health Canada · WHO alerts

About 5% Dextrose (500/1000 mL)

What is in 5% Dextrose (500/1000 mL)?

5% Dextrose (500/1000 mL) contains Anhydrous Dextrose (5%), as solution for infusion, according to its NAFDAC registration record.

Is 5% Dextrose (500/1000 mL) registered with NAFDAC?

Yes. 5% Dextrose (500/1000 mL) is listed on the NAFDAC register under registration number 04-0857, and its registration is active as of 4 November 2026.

Has 5% Dextrose (500/1000 mL) been flagged as fake or recalled?

No WHO falsified or substandard medical product alert currently matches 5% Dextrose (500/1000 mL) in our automatically synced alert list.

How can I check that my pack of 5% Dextrose (500/1000 mL) is genuine?

Run a free authenticity scan with the NAFDAC number 04-0857, your pack's expiry date and batch number to get a Trust Score, compare the pack with the NAFDAC record (ingredient, strength, form, manufacturer), and buy only from licensed pharmacies.

How do I take 5% Dextrose (500/1000 mL)?

Follow your prescription or the leaflet in your pack. The official label says: See product labeling for methotrexate sodium and cytarabine. Elliotts B Solution is intended for intrathecal administration only. Elliotts B Solution does not contain antibacterial preservatives and introduction of contaminated solutions into the cerebrospinal fluid may have extremely serious consequences. Therefore, administration of intrathecal solutions should be accomplishe…

What is 5% Dextrose (500/1000 mL) used for?

Elliotts B Solution is indicated as a diluent for the intrathecal administration of methotrexate sodium and cytarabine for the prevention or treatment of meningeal leukemia or lymphocytic lymphoma. (Summarised from the official U.S. FDA label for anhydrous dextrose. Always follow your doctor or pharmacist.)

Patient reviews

–No reviews yet
5★
0
4★
0
3★
0
2★
0
1★
0
Have you used 5% Dextrose (500/1000 mL)? Share your experience to help other patients. Sign in to review

Reviews are personal experiences from PillVera users, not medical advice. Report side effects to your doctor and to NAFDAC.